Development, effectiveness and cost-effectiveness of a new out-patient Breathlessness Support Service: study protocol of a phase III fast-track randomised controlled trial

BMC Pulmonary Medicine

Volumn 12, Issue , 2012, Pages

  Bausewein, Claudia ^a,b   Jolley, Caroline ^c   Reilly, Charles ^a   Lobo, Paula ^c   Kelly, Jane ^c   Bellas, Helene ^c   Madan, Preety ^c   Panell, Caty ^a   Brink, Elmien ^a   De Biase, Chiara ^a   Gao, Wei ^a   Murphy, Caroline ^a   McCrone, Paul ^a   Moxham, John ^c   Higginson, Irene J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYSIS OF COVARIANCE; ARTICLE; BREATHLESSNESS SUPPORT SERVICE; CAREGIVER BURDEN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY QUESTIONNAIRE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DYSPNEA; FEMALE; HEART FAILURE; HUMAN; INTERSTITIAL LUNG DISEASE; INTERVIEW; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MOTOR NEURON DISEASE; NEOPLASM; OUTPATIENT CARE; PALLIATIVE THERAPY; PATIENT CARE; PHASE 3 CLINICAL TRIAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SPIROMETRY; TREATMENT DURATION; TREATMENT OUTCOME; UNITED KINGDOM; UNIVERSITY HOSPITAL; WALKING;

AGED; AMBULATORY CARE; COST-BENEFIT ANALYSIS; DYSPNEA; FEMALE; HEART FAILURE; HOME CARE SERVICES, HOSPITAL-BASED; HUMANS; LONDON; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT CARE TEAM; PROGRAM DEVELOPMENT; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84866304133     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-12-58     Document Type: Article

References (49)

1. National Institute for Clinical Excellence (NICE) Lung cancer. The diagnosis and treatment of lung cancer. National Collaborating Centre for Acute Care 2005, http://guidance.nice.org.uk/CG121, National Institute for Clinical Excellence (NICE).
2. Katsura H, Kanemaru A, Yamada K, Motegi T, Wakabayashi R, Kida K. Long-term effectiveness of an inpatient pulmonary rehabilitation program for elderly COPD patients: Comparison between young-elderly and old-elderly groups. Respirology 2004, 9:230-236. 10.1111/j.1440-1843.2004.00561.x, 15182274.
3. Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA, Vestbo J. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002, 20(4):799-805. 10.1183/09031936.02.03242002, 12412667.
4. Lynn J, Ely EW, Zhong Z, McNiff KL, Dawson NV, Connors A, Desbiens NA, Claessens M, McCarthy EP. Living and dying with chronic obstructive pulmonary disease. J Am Geriatr Soc 2000, 48(5 Suppl):S91-100.
5. Edmonds P, Karlsen S, Khan S, Addington-Hall J. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 2001, 15(4):287-295. 10.1191/026921601678320278, 12054146.
6. Austin J, Williams R, Ross L, Moseley L, Hutchison S. Randomised controlled trial of cardiac rehabilitation in elderly patients with heart failure. Eur J Heart Fail 2005, 7(3):411-417. 10.1016/j.ejheart.2004.10.004, 15718182.
7. Seow H, Barbera L, Sutradhar R, Howell D, Dudgeon D, Atzema C, Liu Y, Husain A, Sussman J, Earle C. Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. J Clin Oncol 2011, 29(9):1151-1158. 10.1200/JCO.2010.30.7173, 21300920.
8. Reuben DB, Mor V. Dyspnea in terminally ill cancer patients. Chest 1986, 89(2):234-236. 10.1378/chest.89.2.234, 3943383.
9. Escalante CP, Martin CG, Elting LS, Cantor SB, Harle TS, Price KJ, Kish SK, Manzullo EF, Rubenstein EB. Dyspnea in cancer patients: Etiology, resource utilization, and survival-Implications in a managed care world. Cancer 1996, 78(6):1314-1319. 10.1002/(SICI)1097-0142(19960915)78:6<1314::AID-CNCR21>3.0.CO;2-2, 8826956.
10. Higginson IJ. Refractory breathlessness: oxygen or room air?. Lancet 2010, 376(9743):746-748. 10.1016/S0140-6736(10)61346-3, 20816528.
11. D-C Man W, Polkey MI, Donaldson N, Gray BJ, Moxham J. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 2004, 329(7476):1209. 10.1136/bmj.38258.662720.3A, 529363, 15504763.
12. Coats AJS, Adamopoulos S, Meyer TE, Conway J, Sleight P. Effects of physical training in chronic heart failure. Lancet 1990, 335(8681):63-66. 10.1016/0140-6736(90)90536-E, 1967416.
13. Bausewein C, Booth S, Gysels M, Higginson Irene J. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database of Systematic Reviews 2008, 2:CD005623.
14. Bredin M. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ 1999, 318:901-904. 10.1136/bmj.318.7188.901, 27809, 10102851.
15. Corner J, Plant H, A'Hern R, Bailey C. Non-pharmacological intervention for breathlessness in lung cancer. Pall Med 1996, 10(4):299-305.
16. Booth S. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnoea: a qualitative phase 1 study. Palliat Support Care 2006, 4:287-293.
17. Farquhar M, Higginson I, Fagan P, Booth S. The feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease. BMC Palliative Care 2009, 8(1):9. 10.1186/1472-684X-8-9, 2731082, 19583857.
18. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P. Framework for design and evaluation of complex interventions to improve health. BMJ 2000, 321(7262):694-696. 10.1136/bmj.321.7262.694, 1118564, 10987780.
19. Medical Research Council MRC framework for development and evaluation of RCTs for complex interventions to improve health 2000, London, Medical Research Council, Medical Research Council.
20. Higginson I, Vivat B, Silber E, Saleem T, Burman R, Hart S, Edmonds P. Study protocol: delayed intervention randomised controlled trial within the Medical Research Council (MRC) Framework to assess the effectiveness of a new palliative care service. BMC Palliat Care 2006, 5(1):7. 10.1186/1472-684X-5-7, 1615868, 17014714.
21. Moore S, Corner J, Haviland J, Wells M, Salmon E, Normand C, Brada M, Smith I. Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. BMJ 2002, 325(7373):1145. 10.1136/bmj.325.7373.1145, 133453, 12433764.
22. Rabow MW, Dibble SL, Pantilat SZ, McPhee SJ. The Comprehensive Care Team: A Controlled Trial of Outpatient Palliative Medicine Consultation. Arch Intern Med 2004, 164(1):83-91. 10.1001/archinte.164.1.83, 14718327.
23. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003, 327(7414):523-528. 10.1136/bmj.327.7414.523, 192892, 12958109.
24. Jennings Anne L, Davies Andrew N, Higgins Julian PT, Anzures-Cabrera J, Broadley Karen E. Opioids for the palliation of breathlessness in advanced disease and terminal illness. Cochrane Database of Systematic Reviews 2001, 4:CD002066.
25. Abernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE, Marcello J, Young IH, Bull J, Wilcock A, Booth S, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet 2010, 376(9743):784-793. 10.1016/S0140-6736(10)61115-4, 2962424, 20816546.
26. Gysels MH, Higginson IJ. Caring for a person in advanced illness and suffering from breathlessness at home: Threats and resources. Palliat Support Care 2009, 7(02):153-162. 10.1017/S1478951509000200, 19538797.
27. Gysels M, Higginson I. Self-management for breathlessness in COPD: the role of pulmonary rehabilitation. J Chronic Dis 2009, 6(3):133-140.
28. Gysels M, Higginson IJ. Access to Services for Patients with Chronic Obstructive Pulmonary Disease: The Invisibility of Breathlessness. J Pain Symptom Manage 2008, 36(5):451-460. 10.1016/j.jpainsymman.2007.11.008, 18495412.
29. Gysels MH, Higginson IJ. The lived experience of breathlessness and its implications for care: a qualitative comparison in cancer, COPD, heart failure and MND. BMC Palliat Care 2011, 10:15. 10.1186/1472-684X-10-15, 3206451, 22004467.
30. Altman DG. Practical Statistics for Medical Research, First Edition edn 1991, London: Chapman & Hall.
31. Sewell L, Singh SJ, Williams JEA, Collier R, Morgan MDL. How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks. Thorax 2006, 61(9):767-771. 10.1136/thx.2005.048173, 2117104, 16449270.
32. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987, 42(10):773-778. 10.1136/thx.42.10.773, 460950, 3321537.
33. Schunemann HJ, Goldstein R, Mador MJ, McKim D, Stahl E, Puhan M, Griffith LE, Grant B, Austin P, Collins R, et al. A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur Respir J 2005, 25(1):31-40. 10.1183/09031936.04.00029704, 15640320.
34. Gift A, Narsavage G. Validity of the numeric rating scale as a measure of dyspnea. Am J Respir Crit Care Med 1998, 7(3):200-204.
35. Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010, 65(1):21-26. 10.1136/thx.2009.118521, 2795166, 19996336.
36. Hearn J, Higginson IJ. Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. Qual Health Care 1999, 8(4):219-227. 10.1136/qshc.8.4.219, 2483665, 10847883.
37. Garrod R, Paul EA, Wedzicha JA. An evaluation of the reliability and sensitivity of the London Chest Activity of Daily Living Scale (LCADL). Resp Med 2002, 96(9):725-730.
38. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983, 67(6):361-370. 10.1111/j.1600-0447.1983.tb09716.x, 6880820.
39. Williams A. The Role of the EUROQOL Instrument in QALY Calculations Centre for Health Economics. University of York 1995, http://www.york.ac.uk/media/che/documents/papers/discussionpapers/CHE%20Discussion%20Paper%20130.pdf.
40. Bédard M, Molloy DW, Squire L, Dubois S, Lever JA, O'Donnell M. The Zarit Burden Interview. Gerontologist 2001, 41(5):652-657. 10.1093/geront/41.5.652, 11574710.
41. American Thoracic Society Standardization of Spirometry, 1994 Update. ATS. Am J Respir Crit Care Med 1995, 3:1107-1136. American Thoracic Society.
42. American Thoracic Society ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166(1):111-117. American Thoracic Society.
43. Hill K, Jenkins SC, Cecins N, Philippe DL, Hillman DR, Eastwood PR. Estimating Maximum Work Rate During Incremental Cycle Ergometry Testing From Six-Minute Walk Distance in Patients With Chronic Obstructive Pulmonary Disease. Arch Phys Med Rehabil 2008, 89(9):1782-1787. 10.1016/j.apmr.2008.01.020, 18760164.
44. Kasymjanova G, Correa JA, Kreisman H, Dajczman E, Pepe C, Dobson S, Lajeunesse L, Sharma R, Small D. Prognostic Value of the Six-Minute Walk in Advanced Non-small Cell Lung Cancer. J Thorac Oncol 2009, 4(5):602-607. 610.1097/JTO.1090b1013e31819e31877e31818, 10.1097/JTO.0b013e31819e77e8, 19276833.
45. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. N Eng J Med 2004, 350(10):1005-1012.
46. Puhan MA, Guyatt GH, Goldstein R, Mador J, McKim D, Stahl E, Griffith L, Schünemann HJ. Relative responsiveness of the Chronic Respiratory Questionnaire. St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Resp Med 2007, 101(2):308-316.
47. Bausewein C, Booth S, Gysels M, Kuhnbach R, Haberland B, Higginson IJ. Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med 2010, 13(9):1109-1118. 10.1089/jpm.2010.0068, 20836635.
48. Farquhar M, Higginson IJ, Fagan P, Booth S. Results of a pilot investigation into a complex intervention for breathlessness in advanced chronic obstructive pulmonary disease (COPD): Brief report. Palliat Support Care 2010, 2:143-149. Epub 2010 Mar 23.
49. Booth S, Moffat C, Farquhar M, Higginson IJ, Burkin J. Developing a breathlessness intervention service for patients with palliative and supportive care needs, irrespective of diagnosis. J Palliat Care 2011, 27(1):28-36.